Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management - Market Research Reports - Research and Markets

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1055834

Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management

Description:

The advocacy of Key Opinion Leaders (KOLs) has proven to be among the most effective and critical means of building product awareness in the medical and scientific communities.

Indeed, KOL relationship management itself has emerged as its own business discipline, a necessary and challenging component of brand promotion. As one interviewed director put it, “KOL relationship management has changed very quickly. I’ve found that large companies have difficulty adapting in a timely manner.”

This research report examines how leading pharmaceutical companies approach KOL management.

This report identifies the organizational structures, management strategies and tactics, and critical success factors associated with KOL management excellence. Pharma executives can use this benchmarking research to learn best practices in KOL management and discover how they can maximize KOL relationships to benefit their own products and therapies.

KEY FINDINGS:

- Marketing has functional responsibility for KOL Management at 73 percent of companies surveyed.
- Medical Affairs also shares some responsibility for KOL Management at 61 percent of benchmark partner companies.
- A majority (59 percent) of respondents reported that Medical Science Liaisons (MSLs) are either moderately or highly involved in KOL development at their companies. Among Top 30 pharma respondents, that figure jumps to 80 percent.
- More than one-fifth of participant companies report that they have no method for evaluating KOL activities.

KEY TOPICS:

- KOL Segmentation and Behavior Drivers
- KOL Roles Over Product Lifecycle
- KOL Management Models
- Role of Medical Science Liaisons (MSLs) in Managing KOLs
- Emerging Trends in KOL Management
- Innovative Practices in KOL Management
- Critical Success Factors in KOL Management
- Most Difficult Challenges in KOL Management

KEY METRICS:

- Functional Responsibility for KOL Management
- Budgetary Responsibility for KOL Management
- Optimal KOL Management Organizational Structure
- Highly Effective Tactics for KOL Management
- National and Regional KOL Contact
- Level of MSL Involvement in KOL Management
- KOL Evaluation
- KOL Involvement Satisfaction
- How KOL Management is Valued Internally
- Recent Changes in KOL Management
- Future Changes in KOL Management

Contents:

RESEARCH OVERVIEW
- Research Objective and Methodology
- Benchmark Class
- Respondent Characteristics

KEY FINDINGS & INSIGHTS
- Organizational Structure
- Strategies and Tactics
- Management Roles, Tools and Activities
- Role of MSLs in Managing KOLs
- Measuring the Work of MSLs

ORGANIZATIONAL STRUCTURE
- Dedication of KOL Management Function
- Organizational Responsibility for KOL Management
- Optimal KOL Management Organizational Structure
- Recent and Planned Changes in KOL Management
- “Optimal” KOL Management Model

SEGMENTATION, ALIGNMENT AND USE
- KOL Segmentation and Behavior Drivers
- KOL Roles Over Product Lifecycle
- KOL Structure Should Evolve with the Company

MANAGEMENT ROLES, TOOLS AND ACTIVITIES
- Highly Effective Tactics for KOL Management
- Highly Important Approaches to KOL Management
- Point of Contact for KOL Management
- National vs. Regional KOL Contact
- Software Used in KOL Management
- MSLs Involvement in KOL Management
- How KOL Activities are Evaluated
- What KOLs Value Most
- How KOL Satisfaction is Ensured
- How KOL Management is Valued Internally

INNOVATIVE PRACTICES, OPPORTUNITIES AND CHALLENGES
- Recognized Innovative Practices are Uncommon
- What Differentiates the Better Companies
- Critical Success Factors
- Most Difficult Challenges in KOL Management
- Emerging Trends

APPENDIX
- Additional Quotes

ABOUT BEST PRACTICES, LLC

Companies Mentioned

- Abbott Laboratories - URL Pharma - Transoma Medical - Steris Corporation - Spectrum Pharmaceutical - Skila - Rivermark LLC - RBP Chemical Corporation - Promeco SA de CV - Noven Therapeuticals - Nobel Biocare - Lundbeck - Kendle International - Inspire Pharmaceuticals - Impact Communications - Esteve - Becton Dickinson - Anesiva - Vistakon - Teva Pharmaceutical Industries Ltd - Solvay Pharmaceuticals - Shire - Sanofi-Aventis - Pfizer - Novartis - Myriad - Merck - Medrad - Johnson & Johnson - Janssen Cilag Pharmaceutical - Invitrogen - Innovex Global - Genentech - Ethicon Endo-Surgery Inc - EMD Serono - Cubist Pharmaceuticals - Covidien - Celgene - Bristol-Myers Squibb - Biogen Idec - Bayer Schering AG - Baxter Healthcare - Amgen - Alcon Laboratories

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/1055834

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 29/11/2009 04:53:59

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management
Web Address:
http://www.researchandmarkets.com/reports/1055834
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

	Format	Quantity	Price
	CD ROM		€5,564.00 + EUR€ 50.00 Shipping/Handling *
	Hard Copy (Hard Back)		€5,564.00 + EUR€ 50.00 Shipping/Handling *
	Electronic (PDF) - Single User		€5,564.00
	Electronic (PDF) - Site License		€16,692.00
	Electronic (PDF) - Enterprisewide		€27,820.00

* Shipping/Handling is only charged once per order.

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 29/11/2009 04:53:59

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)